Defence Therapeutics Receives USPTO Allowance for Patent Application Covering Next-Gen ADC TechnologyJune 09, 2025 3:15 AM EDT | Source: Defence Therapeutics Inc.Montreal, Quebec--(Newsfile Corp. - June 9, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in drug delivery technologies, is pleased to announce that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance  ...